Cronos Group Inc (CRON)
2.07
-0.10
(-4.61%)
USD |
NASDAQ |
Nov 14, 16:00
2.08
+0.01
(+0.48%)
Pre-Market: 09:19
Cronos Group Revenue (Quarterly): 27.76M for June 30, 2024
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 27.76M |
| March 31, 2024 | 25.29M |
| December 31, 2023 | 23.92M |
| September 30, 2023 | 24.81M |
| June 30, 2023 | 19.02M |
| March 31, 2023 | 19.50M |
| December 31, 2022 | 22.03M |
| September 30, 2022 | 20.41M |
| June 30, 2022 | 21.60M |
| March 31, 2022 | 25.03M |
| December 31, 2021 | 15.92M |
| September 30, 2021 | 20.41M |
| June 30, 2021 | 15.62M |
| March 31, 2021 | 12.61M |
| December 31, 2020 | 17.05M |
| September 30, 2020 | 11.36M |
| Date | Value |
|---|---|
| June 30, 2020 | 9.883M |
| March 31, 2020 | 8.432M |
| December 31, 2019 | 7.308M |
| September 30, 2019 | 5.785M |
| June 30, 2019 | 7.653M |
| March 31, 2019 | 3.004M |
| December 31, 2018 | 4.304M |
| September 30, 2018 | 2.910M |
| June 30, 2018 | 2.581M |
| March 31, 2018 | 2.280M |
| December 31, 2017 | 1.155M |
| September 30, 2017 | 1.059M |
| June 30, 2017 | 0.4944M |
| March 31, 2017 | 0.3854M |
| December 31, 2016 | 0.3181M |
| September 30, 2016 | 0.094M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
7.308M
Minimum
Dec 2019
27.76M
Maximum
Jun 2024
18.31M
Average
19.50M
Median
Mar 2023
Revenue (Quarterly) Benchmarks
| Tilray Brands Inc | 200.04M |
| Aurinia Pharmaceuticals Inc | 67.77M |
| Edesa Biotech Inc | -- |
| Lexaria Bioscience Corp | 0.084M |
| Xenon Pharmaceuticals Inc | -- |
Revenue (Quarterly) Related Metrics
| Net Income (Quarterly) | -8.757M |
| Total Expenses (Quarterly) | 42.78M |
| EPS Diluted (Quarterly) | -0.02 |
| Enterprise Value | -60.39M |
| Gross Profit Margin (Quarterly) | 22.68% |
| Profit Margin (Quarterly) | -31.54% |
| Earnings Yield | -6.97% |
| Normalized Earnings Yield | -0.2776 |